| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Alemtuzumab (Campath-1H) in the treatment of chronic lymphocytic leukemia. | Oncogene | 2007 | 1.27 |
| 2 | Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridol. | Leukemia | 2011 | 1.07 |
| 3 | Outcomes of hematopoietic SCT recipients with rhinovirus infection: a matched, case-control study. | Bone Marrow Transplant | 2013 | 0.81 |